Key facts
- This page summarizes Gail M. Farfel's Form 4 filing for ProMIS Neurosciences Inc. (PMN).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 25 Aug 2023, 16:19.
Gail M. Farfel - 23 Aug 2023 Form 4 Insider Report for ProMIS Neurosciences Inc. (PMN)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- PMN
- Reported as of
- 23 Aug 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 25 Aug 2023, 16:19:41 UTC
- Prior SEC filing
- 23 Jun 2023
- Next SEC filing
- 27 Sep 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Max A. Milbury, Attorney-in-Fact for Gail M. Farfel
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Gail M. Farfel filed Form 4 for ProMIS Neurosciences Inc. (PMN) on 25 Aug 2023.
Change
- Previous filing in this sequence was filed on 23 Jun 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PMN
transaction
Common Shares
Award
- Transaction value
- Shares
- +53,192
- Change %
- +2660%
- Price
- Shares after
- 55,192
- Date
- 23 Aug 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PMN
transaction
Derivative
Warrants to purchase Common Shares
Award
- Transaction value
- Shares
- +53,192
- Change %
- Price
- Shares after
- 53,192
- Date
- 23 Aug 2023
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 53,192
- Exercise price
- $1.75
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
On August 23, 2023, pursuant to a Unit Purchase Agreement entered into by the Company with selected investors (the "Offering"), the Reporting Person acquired 53,192 common share units (each, a "Common Share Unit"), each unit consisting of one of the Company's common shares, no par value (the "Common Shares"), and one warrant to purchase one Common Share. The purchase price for each Common Share Unit was $1.88 per Common Share Unit.